Mr. Mohammed Jemal | Pharmacology | Research Excellence Award

Debre Markos University | Ethiopia

Mr. Mohammed Jemal is a dedicated biochemist, educator, and emerging research leader whose work bridges biomedical sciences, clinical research, and public health. He holds an advanced academic background in biochemistry and public health, which has shaped his holistic understanding of human physiology, metabolic disorders, infectious diseases, and molecular mechanisms of health and disease. His academic training laid a strong foundation for a career committed to scientific investigation, innovation, and community-centered healthcare improvement.Mr. Jemal serves as a Lecturer in Biochemistry and the Head of the Biochemistry Unit in the Department of Biomedical Sciences at the School of Medicine, Debre Markos University, Ethiopia. In this dual role, he contributes significantly to curriculum development, academic leadership, student mentorship, research project coordination, and institutional capacity-building. His earlier roles as Assistant Lecturer and Graduate Assistant Lecturer strengthened his skills in teaching, laboratory instruction, and academic administration. Through these experiences, he has built a strong reputation for academic excellence, professional discipline, and commitment to nurturing young scholars.His research portfolio reflects a deep interest in metabolic health, HIV-related complications, non-communicable diseases, and molecular mechanisms in chronic illnesses. He has authored and co-authored several influential publications in reputable peer-reviewed journals. Among his notable works are “Blood Glucose Level and Serum Lipid Profiles among People Living with HIV on Dolutegravir-Based versus Efavirenz-Based cART: A Comparative Cross-Sectional Study,” “The Evolving Roles of Fetuin-A in Type 2 Diabetes Mellitus and Its Potential Clinical Implications: A Review,” “Overweight and Obesity Among People Living With HIV on Dolutegravir- and Efavirenz-Based Therapies: A Comparative Cross-Sectional Study,” “Ketogenic Diets and Their Therapeutic Potential on Breast Cancer: A Systemic Review,” “Metabolic Syndrome Among People Living with HIV on Dolutegravir and Efavirenz-Based Antiretroviral Therapy in Ethiopia: A Comparative Cross-Sectional Study,” and “Non-Metabolic Enzyme Function of Pyruvate Kinase M2 in Breast Cancer.” These publications highlight his commitment to addressing pressing biomedical challenges, especially those affecting vulnerable populations.Beyond publishing, Mr. Jemal has secured competitive institutional funding for research projects focusing on hepatotoxicity, diabetes models, HIV patient care, and clinical electrophysiology. His projects involving medicinal plants, metabolic biomarkers, and community-based HIV service delivery demonstrate his multidisciplinary research capabilities. He also contributes extensively to academic quality assurance through curriculum review, peer reviewing for international journals, and participation in institutional research committees.Through unwavering dedication to teaching, research, and service, Mr. Mohammed Jemal continues to influence the scientific community while shaping the next generation of healthcare professionals. His intellectual curiosity, leadership skills, and commitment to evidence-based practice position him as a rising figure in biomedical research and academic excellence.

Profile: Google Scholar

Featured Publications

Jemal M, Molla TS, Dejenie TA. Ketogenic diets and their therapeutic potential on breast cancer: a systemic review. Cancer Manag Res. 2021;33:9147-9155.

Jemal M. A review of dolutegravir-associated weight gain and secondary metabolic comorbidities. SAGE Open Med. 2024;12:20503121241260613.

Baylie T, Kasaw M, Getie G, Jemal M, Ahmed H, Nigatu A, Bogale M. The role of miRNAs as biomarkers in breast cancer. Front Oncol. 2024;14:1374821.

Jemal M, Molla TS, Medhin MTG, Abebe EC, et al. Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART: a comparative cross-sectional study. Ann Med. 2023;55(2):2295435.

Waritu NC, Nair SKP, Birhan B, Adugna T, Awgichew GB, Jemal M. Serum lipid profiles, blood glucose, and high-sensitivity C-reactive protein levels among people living with HIV taking dolutegravir and ritonavir-boosted atazanavir-based therapy. HIV AIDS Res Palliat Care. 2024;17:17-32.

Abebaw D, Akelew Y, Adugna A, Teffera ZH, Tegegne BA, Fenta A, … Jemal M. Extracellular vesicles: immunomodulation, diagnosis, and promising therapeutic roles for rheumatoid arthritis. Front Immunol. 2024;15:1499929.

Abebaw D, Akelew Y, Adugna A, Tegegne BA, Teffera ZH, Belayneh M, … Jemal M. Immunomodulatory properties of the gut microbiome: diagnostic and therapeutic potential for rheumatoid arthritis. Clin Exp Med. 2025;25(1):226.